Gmo Product Platform (TSE:3695) EBITDA Margin %: 0.00% (As of Dec. 2025)


TSE:3695 Gmo Product Platform Inc TSE:3695
71 GF Score
Price 円1,440.00
GF Value 円1,488.58
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Gmo Product Platform EBITDA Margin %?

Gmo Product Platform TSE:3695 +0.14% 71 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:3695 with a GF Score™ of 71/100 and a GF Value™ of 円1,488.58 (Fairly Valued). The stock has 3 warning signs investors should review. Among 2,813 Software companies, Gmo Product Platform ranks better than 67.72% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Gmo Product Platform's EBITDA for the three months ended in Dec. 2025 was 円0 Mil. Gmo Product Platform's Revenue for the three months ended in Dec. 2025 was 円0 Mil. Therefore, Gmo Product Platform's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.


Gmo Product Platform  (TSE:3695) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Gmo Product Platform EBITDA Margin % Related Terms


Gmo Product Platform EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Gmo Product Platform's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gmo Product Platform EBITDA Margin % Chart

Gmo Product Platform Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.12 10.47 10.13 7.05 6.26

Gmo Product Platform Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.40 11.29 0.00 0.00 17.90

TSE:3695 vs MSFT, ORCL, PLTR: EBITDA Margin % Comparison

For the Software - Infrastructure subindustry, Gmo Product Platform's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gmo Product Platform EBITDA Margin % vs Software Industry

For the Software industry and Technology sector, Gmo Product Platform's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Gmo Product Platform's EBITDA Margin % falls into.


TSE:3695
71GF Score
Gmo Product Platform Inc TSE:3695
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gmo Product Platform EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Gmo Product Platform's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=426.703/6818.184
=6.26 %

Gmo Product Platform's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Gmo Product Platform (TSE:3695) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gmo Product Platform and its competitors. Over the past decade, Gmo Product Platform's EBITDA Margin % has ranged from 6.26 to 14.72. According to the industry distribution chart, Gmo Product Platform ranks #908 out of 2813 companies in the Software industry, placing it in the top 32.3%.
Is Gmo Product Platform's EBITDA Margin % too high?
Gmo Product Platform's current EBITDA Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 6.26 to a high of 14.72. Based on the distribution chart, Gmo Product Platform ranks #908 out of 2813 companies in the Software industry, which is above the industry midpoint. Overall, Gmo Product Platform has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gmo Product Platform's EBITDA Margin % compare to MSFT and ORCL?
According to the Software industry distribution chart, Gmo Product Platform ranks #908 out of 2813 companies for EBITDA Margin %. This puts Gmo Product Platform in the upper half of its industry. The industry median EBITDA Margin % is 8.09. Historically, Gmo Product Platform's own EBITDA Margin % has ranged from 6.26 to 14.72 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.09, based on 2,813 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gmo Product Platform and its competitors. For the Software industry, the median EBITDA Margin % is 8.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gmo Product Platform's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gmo Product Platform stock overvalued right now?
Based on GuruFocus' analysis, Gmo Product Platform (TSE:3695) is currently considered Fairly Valued. The stock's GF Value™ is 円1,488.58, compared to a current price of 円1,440.00 — trading 3.3% below its estimated fair value. The current EBITDA Margin % is 0.00%. Gmo Product Platform's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Gmo Product Platform (TSE:3695), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gmo Product Platform (TSE:3695) Overvalued in 2026?

Based on GuruFocus' analysis, Gmo Product Platform stock appears to be undervalued. The current stock price of 円1,440.00 is trading 3.3% below its estimated GF Value™ of 円1,488.58. GuruFocus considers Gmo Product Platform to be Fairly Valued.

Key valuation signals for TSE:3695:

  • EBITDA Margin %: 0.00%
  • GF Value™: 円1,488.58 vs. price of 円1,440.00 (3.3% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the TSE:3695 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gmo Product Platform Business Description

Address Cerulean Tower No. 26, No. 1 Sakuragaoka Town, Shibuya-ku, Tokyo, JPN, 150-8512
Gmo Product Platform Inc offers online payment and business-to-business payment platform services that help startups, tech companies, and SMEs improve payment processing and operational efficiency. The solutions of the company support various business models with digital payment infrastructure and finance-related services.
71GF Score

Get the complete analysis for TSE:3695

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,440.00
Price
円1,488.58
GF Value